Aibolit Technologies, LLC

Aibolit Technologies, LLC has 2 AI-enabled medical devices on the FDA list. The first decision was on January 7, 2022 and the most recent on January 12, 2023 (AIBOLIT 3D+). Its most common review panel is Radiology (2 devices).